Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
About Velorum Therapeutics
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Company details
Funding
Total raised
$500K
Last stage
Seed
Investors
Founders
Pouya Modareszadeh
Twin brother and scientist-turned-entrepreneur; graduated summa cum laude (4.0) from UT Dallas; building new medicines at Velorum Therapeutics (YC W24).
LinkedIn
Parsa Modareszadeh
Co-Founder and President @ Velorum Therapeutics. Goldwater Scholar. Working to create breakthrough medicines for devastating diseases.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.